IL-21-treated NK cells secreted high levels of IFN-γ, which enhanced NK cell activation through extracellular signal-regulated kinase and signal transducer and activator of transcription (STAT) 1 signaling pathway, thus inhibiting tumor growth. The gene discussed is IL21; the disease is neoplasm.